CircSLC16A12 Absence Inhibits High Glucose-Induced Dysfunction in Retinal Microvascular Endothelial Cells through Mediating miR-140-3p/FGF2 Axis in Diabetic Retinopathy

References

• Antonetti DA, Silva PS, Stitt AW. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol. 2021;17(4):195–206. doi:10.1038/s41574-020-00451-4.
   PubMed Web of Science ®Google Scholar
• Stewart JM, Coassin M, Schwartz DM. Diabetic retinopathy. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, editors. Endotext. South Dartmouth (MA): MDText.com, Inc, 2000.
   Google Scholar
• Rudraraju M, Narayanan SP, Somanath PR. Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy. Pharmacol Res. 2020;161:105115. doi:10.1016/j.phrs.2020.105115.
   PubMed Web of Science ®Google Scholar
• Yang X, Yu XW, Zhang DD, Fan ZG. Blood-retinal barrier as a converging pivot in understanding the initiation and development of retinal diseases. Chin Med J. 2020;133(21):2586–2594. doi:10.1097/cm9.0000000000001015.
   PubMed Web of Science ®Google Scholar
• Chen Q, Tan F, Wu Y, Zhuang X, Wu C, Zhou Y, Li Y, Cheng D, Wang J, Lu F, et al. Characteristics of retinal structural and microvascular alterations in early type 2 diabetic patients. Invest Ophthalmol Vis Sci. 2018;59(5):2110–2118. doi:10.1167/iovs.17-23193.
   PubMed Web of Science ®Google Scholar
• Hammes HP, Feng Y, Pfister F, Brownlee M. Diabetic retinopathy: targeting vasoregression. Diabetes. 2011;60(1):9–16. doi:10.2337/db10-0454.
   PubMed Web of Science ®Google Scholar
• He M, Zhou R, Liu S, Cheng W, Wang W. Circular RNAs: potential star molecules involved in diabetic retinopathy. Curr Eye Res. 2021;46(3):277–283. doi:10.1080/02713683.2020.1812086.
   PubMed Web of Science ®Google Scholar
• Guo N, Liu XF, Pant OP, Zhou DD, Hao JL, Lu CW. Circular RNAs: novel promising biomarkers in ocular diseases. Int J Med Sci. 2019;16(4):513–518. doi:10.7150/ijms.29750.
   PubMed Web of Science ®Google Scholar
• Zeng Q, Liu J. Silencing circ_0001879 inhibits the proliferation and migration of human retinal microvascular endothelial cells under high-glucose conditions via modulating miR-30-3p. Gene. 2020;760:144992 doi:10.1016/j.gene.2020.144992.
   PubMed Web of Science ®Google Scholar
• Zhang SJ, Chen X, Li CP, Li XM, Liu C, Liu BH, Shan K, Jiang Q, Zhao C, Yan B. Identification and characterization of circular RNAs as a new class of putative biomarkers in diabetes retinopathy. Invest Ophthalmol Vis Sci. 2017;58(14):6500–6509. doi:10.1167/iovs.17-22698.
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–352. doi:10.1038/nature12986.
   PubMed Web of Science ®Google Scholar
• Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–283. doi:10.1038/nrg.2016.20.
   PubMed Web of Science ®Google Scholar
• Bi J, Liu H, Cai Z, Dong W, Jiang N, Yang M, Huang J, Lin T. Circ-BPTF promotes bladder cancer progression and recurrence through the miR-31-5p/RAB27A axis. Aging. 2018;10(8):1964–1976. doi:10.18632/aging.101520.
   PubMedGoogle Scholar
• Zou J, Liu KC, Wang WP, Xu Y. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy. Life Sci. 2020;256:117888. doi:10.1016/j.lfs.2020.117888.
   PubMed Web of Science ®Google Scholar
• Sosna T. History of diagnosis and therapy of diabetic retinopathy. Vnitr Lek. 2016;62(11 Suppl 4):S136–S41. doi:
   PubMedGoogle Scholar
• Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388. doi:10.1038/nature11993.
   PubMed Web of Science ®Google Scholar
• Lasda E, Parker R. Circular RNAs: diversity of form and function. RNA. 2014;20(12):1829–1842. doi:10.1261/rna.047126.114.
   PubMed Web of Science ®Google Scholar
• Cannell IG, Kong YW, Bushell M. 2008. How do microRNAs regulate gene expression? Biochem Soc Trans. 36(Pt 6):1224–1231. doi:10.1042/bst0361224.
   PubMedGoogle Scholar
• Ni WJ, Leng XM. Dynamic miRNA-mRNA paradigms: new faces of miRNAs. Biochem Biophys Rep. 2015;4:337–341. doi:10.1016/j.bbrep.2015.10.011.
   PubMedGoogle Scholar
• Tripathi BK, Srivastava AK. Diabetes mellitus: complications and therapeutics. Med Sci Monit. 2006;12(7):Ra130–47.
   PubMed Web of Science ®Google Scholar
• Shukla UV, Tripathy K. Diabetic Retinopathy. StatPearls. Treasure Island (FL): StatPearls Publishing, 2021.
   Google Scholar
• Lechner J, O'Leary OE, Stitt AW. The pathology associated with diabetic retinopathy. Vision Res. 2017;139:7–14. doi:10.1016/j.visres.2017.04.003.
   PubMed Web of Science ®Google Scholar
• Chang KC, Snow A, LaBarbera DV, Petrash JM. Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells. Chem Biol Interact. 2015;234:254–260. doi:10.1016/j.cbi.2014.10.007.
   PubMed Web of Science ®Google Scholar
• Salzman J. Circular RNA expression: its potential regulation and function. Trends Genet. 2016;32(5):309–316. doi:10.1016/j.tig.2016.03.002.
   PubMed Web of Science ®Google Scholar
• Barrett SP, Salzman J. Circular RNAs: analysis, expression and potential functions. Development. 2016;143(11):1838–1847. doi:10.1242/dev.128074.
   PubMed Web of Science ®Google Scholar
• Gu Y, Ke G, Wang L, Zhou E, Zhu K, Wei Y. Altered expression profile of circular RNAs in the serum of patients with diabetic retinopathy revealed by microarray. Ophthalmic Res. 2017;58(3):176–184. doi:10.1159/000479156.
   PubMed Web of Science ®Google Scholar
• Zhu K, Hu X, Chen H, Li F, Yin N, Liu AL, Shan K, Qin YW, Huang X, Chang Q, et al. Downregulation of circRNA DMNT3B contributes to diabetic retinal vascular dysfunction through targeting miR-20b-5p and BAMBI. EBioMedicine. 2019;49:341–353. doi:10.1016/j.ebiom.2019.10.004.
   PubMed Web of Science ®Google Scholar
• Meng X, Li X, Zhang P, Wang J, Zhou Y, Chen M. Circular RNA: an emerging key player in RNA world. Brief Bioinform. 2017;18(4):547–557. doi:10.1093/bib/bbw045.
   PubMed Web of Science ®Google Scholar
• Jiang W, Li T, Wang J, Jiao R, Shi X, Huang X, Ji G. miR-140-3p suppresses cell growth and induces apoptosis in colorectal cancer by targeting PD-L1. Onco Targets Ther. 2019;12:10275–10285. ( doi:10.2147/OTT.S226465.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen J, Wang X, Wang K. miR-140-3p inhibits bladder cancer cell proliferation and invasion by targeting FOXQ1. Aging. 2020;12(20):20366–20379. doi:10.18632/aging.103828.
   PubMedGoogle Scholar
• Zhou Y, Wang B, Wang Y, Chen G, Lian Q, Wang H. miR-140-3p inhibits breast cancer proliferation and migration by directly regulating the expression of tripartite motif 28. Oncol Lett. 2019;17(4):3835–3841. doi:10.3892/ol.2019.10038.
   PubMed Web of Science ®Google Scholar
• Ma J, Zhang F, Sun P. miR-140-3p impedes the proliferation of human cervical cancer cells by targeting RRM2 to induce cell-cycle arrest and early apoptosis. Bioorg Med Chem. 2020;28(3):115283. doi:10.1016/j.bmc.2019.115283.
   PubMed Web of Science ®Google Scholar
• Collares CV, Evangelista AF, Xavier DJ, Rassi DM, Arns T, Foss-Freitas MC, Foss MC, Puthier D, Sakamoto-Hojo ET, Passos GA, et al. Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients. BMC Res Notes. 2013;6:491. doi:10.1186/1756-0500-6-491.
   PubMedGoogle Scholar
• Wang D, Wang H, Liu C, Mu X, Cheng S. Hyperglycemia inhibition of endothelial miR-140-3p mediates angiogenic dysfunction in diabetes mellitus. J Diabetes Complications. 2019;33(5):374–382. doi:10.1016/j.jdiacomp.2019.02.001.
   PubMed Web of Science ®Google Scholar
• Chen C, Lin S, Zhou L, Wang J, Chen J, Yu R, Luo H, Lu J, Xue Z, Chen M. MicroRNA-127-5p attenuates severe pneumonia via tumor necrosis factor receptor-associated factor 1. Exp Ther Med. 2020;20(3):2856–2862. doi:10.3892/etm.2020.8997.
   PubMed Web of Science ®Google Scholar
• Tasena H, Faiz A, Timens W, Noordhoek J, Hylkema MN, Gosens R, Hiemstra PS, Spira A, Postma DS, Tew GW, et al. microRNA-mRNA regulatory networks underlying chronic mucus hypersecretion in COPD. Eur Respir J. 2018;52(3):1701556. doi:10.1183/13993003.01556-2017.
   PubMed Web of Science ®Google Scholar
• Gershanov S, Toledano H, Michowiz S, Barinfeld O, Pinhasov A, Goldenberg-Cohen N, Salmon-Divon M. MicroRNA-mRNA expression profiles associated with medulloblastoma subgroup 4. CMAR. 2018;10:339–352. doi:10.2147/CMAR.S156709.
   Google Scholar
• Gu C, Draga D, Zhou C, Su T, Zou C, Gu Q, Lahm T, Zheng Z, Qiu Q. miR-590-3p inhibits pyroptosis in diabetic retinopathy by targeting NLRP1 and inactivating the NOX4 signaling pathway. Invest Ophthalmol Vis Sci. 2019;60(13):4215–4223. doi:10.1167/iovs.19-27825.
   PubMed Web of Science ®Google Scholar
• Wang M, Zheng H, Zhou X, Zhang J, Shao G. miR-122 promotes diabetic retinopathy through targeting TIMP3. Anim Cells Syst (Seoul)). 2020;24(5):275–281. doi:10.1080/19768354.2020.1816580.
   PubMed Web of Science ®Google Scholar
• Simó R, Carrasco E, García-Ramírez M, Hernández C. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev. 2006;2(1):71–98. doi:10.2174/157339906775473671.
   PubMedGoogle Scholar
• Qazi Y, Maddula S, Ambati BK. Mediators of ocular angiogenesis. J Genet. 2009;88(4):495–515. doi:10.1007/s12041-009-0068-0.
   PubMed Web of Science ®Google Scholar
• Wang J, Yao Y, Wang K, Li J, Chu T, Shen H. MicroRNA-148a-3p alleviates high glucose-induced diabetic retinopathy by targeting TGFB2 and FGF2. Acta Diabetol. 2020;57(12):1435–1443. doi:10.1007/s00592-020-01569-7.
   PubMed Web of Science ®Google Scholar